Lord, Abbett & Co
OM icon

Lord, Abbett & Co’s Outset Medical OM Stock Holding History

Lord, Abbett & Co’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,862
Closed -$10.1M – 609
2022
Q1 		$10.1M Buy
14,862
+270
+2% +$162K 0.03% 461
2021
Q4 		$10.1M Sell
14,592
-141
-1% -$104K 0.02% 485
2021
Q3 		$10.9M Buy
14,733
+3,347
+29% +$2.28M 0.03% 517
2021
Q2 		$8.54M Sell
11,386
-6,153
-35% -$4.7M 0.02% 554
2021
Q1 		$14.3M Buy
17,539
+4,289
+32% +$3.31M 0.04% 466
2020
Q4 		$11.3M Buy
13,250
+3,865
+41% +$2.98M 0.03% 502
2020
Q3 		$7.04M Buy
+9,385
New +$7.71M 0.02% 524

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Lord, Abbett & Co's OM Position: Q2 2022 in Review

Lord, Abbett & Co sold out of Outset Medical (OM) in Q2 2022, closing a stake of 14,862 shares — an estimated $10.1M sold.

Lord, Abbett & Co first reported a position in OM in Q3 2020 and held it in 7 quarters. The position peaked at $14.3M in Q1 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • Lord, Abbett & Co reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 14,862 Outset Medical shares in Q2 2022, an estimated $10.1M.
  • Lord, Abbett & Co first reported a position in Outset Medical in Q3 2020 and held it in 7 quarters.
  • Lord, Abbett & Co's Outset Medical position peaked at $14.3M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.